Central pathways mediating adenosine-induced hypothermia

      Hypothermia is a potential protective treatment to reduce stroke damage following myocardial infarction, brain hemorrhage or brain ischemia. The protective potential accrues from the reduced cellular metabolism and oxygen demand that accompanies a lowered body temperature, allowing improved survival of tissue in the hypoxic environment of ischemia. Pharmacological blockade of thermogenesis could provide an effective adjunct to external cooling for the induction of a hypothermic, hypometabolic state. Hypothermia and a torpor-like state can be induced in rat, as in hibernating animals, by activation of central A1AR (Tupone, et. al., J Neurosci 33:14512–25, 2013). This state is characterized by a reduced metabolism, body temperature, and cardiovascular and cortical functions (e.g., lower EEG amplitude). We applied this pharmacological approach to induce hypothermia in rat models of stroke: 1) brain ischemic stroke using a middle cerebral artery occlusion (MCAO) and 2) subarachnoid hemorrhage (SAH), which is accompanied by neurogenic fever (NF), a centrally-generated hyperthermia that is resistant to standard antipyretic treatment. Deep hypothermia induced by central activation of A1AR, which blocked brown adipose tissue and shivering thermogenesis, contributed to a significantly reduced infarct size following MCAO and to a marked reduction in the NF hyperthermia following SAH. In conclusion, pharmacological activation of central A1AR combined with a cold ambient temperature induces a deep hypothermia and reduces overall metabolism, and thus represents a potentially useful approach in the treatment of stroke and NF. Supported by Collins Medical Trust Grant (DT), NIH R01NS40987 (SM), Merit Award Department of Veterans Affairs (JC).
      To read this article in full you will need to make a payment